Header cover image

Taiwanese (TAIEX) Drug Retail Industry Analysis

UpdatedJul 26, 2024
DataAggregated Company Financials
Companies5
  • 7D-0.5%
  • 3M-9.3%
  • 1Y-33.1%
  • YTDn/a

Over the last 7 days, the Drug Retail industry has dropped 1.1%, driven by Great Tree Pharmacy declining 4.9%. Meanwhile, MARX Biotech actually outperformed within the industry, gaining 17% in the last week. However, the industry is down 33% over the past year. Looking forward, earnings are forecast to grow by 16% annually.

Industry Valuation and Performance

Has the Taiwanese Drug Retail Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 26 Jul 2024NT$44.2bNT$30.7bNT$873.1m80.3x50.6x1.4x
Sun, 23 Jun 2024NT$46.5bNT$30.7bNT$873.1m81x53.2x1.5x
Tue, 21 May 2024NT$48.3bNT$30.7bNT$873.1m83.6x55.4x1.6x
Thu, 18 Apr 2024NT$49.5bNT$30.3bNT$935.7m58.9x52.9x1.6x
Sat, 16 Mar 2024NT$54.5bNT$30.3bNT$974.4m57.4x55.9x1.8x
Mon, 12 Feb 2024NT$56.3bNT$29.9bNT$964.0m62x58.4x1.9x
Wed, 10 Jan 2024NT$52.6bNT$26.8bNT$949.0m58.2x55.4x2x
Fri, 08 Dec 2023NT$53.4bNT$26.8bNT$949.0m59.1x56.3x2x
Sun, 05 Nov 2023NT$53.3bNT$26.3bNT$1.0b45.6x52.2x2x
Tue, 03 Oct 2023NT$54.7bNT$26.3bNT$1.0b47.4x53.6x2.1x
Thu, 31 Aug 2023NT$53.4bNT$26.3bNT$1.0b46.7x52.3x2x
Sat, 29 Jul 2023NT$55.4bNT$26.7bNT$1.3b26.8x43.9x2.1x
Mon, 26 Jun 2023NT$50.2bNT$26.8bNT$1.3b23.5x39.8x1.9x
Wed, 24 May 2023NT$50.2bNT$26.6bNT$1.3b24.7x39.4x1.9x
Fri, 21 Apr 2023NT$51.0bNT$25.9bNT$1.2b22.1x41.9x2x
Sun, 19 Mar 2023NT$45.4bNT$25.8bNT$1.2b17.4x37.2x1.8x
Tue, 14 Feb 2023NT$39.9bNT$25.1bNT$1.2b15.4x34.3x1.6x
Thu, 12 Jan 2023NT$38.7bNT$25.1bNT$1.2b15.8x33.2x1.5x
Sat, 10 Dec 2022NT$35.5bNT$25.1bNT$1.2b14.9x30.5x1.4x
Mon, 07 Nov 2022NT$31.8bNT$24.3bNT$1.1b20.1x30.3x1.3x
Wed, 05 Oct 2022NT$32.8bNT$24.3bNT$1.1b19.9x31.2x1.4x
Fri, 02 Sep 2022NT$34.9bNT$24.3bNT$1.1b21.7x33.2x1.4x
Sun, 31 Jul 2022NT$29.5bNT$22.5bNT$789.4m33.5x37.4x1.3x
Tue, 28 Jun 2022NT$29.4bNT$22.5bNT$789.4m35.4x37.2x1.3x
Thu, 26 May 2022NT$31.8bNT$22.5bNT$789.4m36.6x40.3x1.4x
Sat, 23 Apr 2022NT$36.9bNT$21.6bNT$739.6m47.4x50x1.7x
Mon, 21 Mar 2022NT$31.8bNT$21.7bNT$740.2m35.6x43x1.5x
Wed, 16 Feb 2022NT$22.8bNT$20.9bNT$698.1m30.8x32.6x1.1x
Fri, 14 Jan 2022NT$21.5bNT$20.9bNT$698.1m31.3x30.8x1x
Sun, 12 Dec 2021NT$23.2bNT$20.9bNT$698.1m31.4x33.2x1.1x
Tue, 09 Nov 2021NT$16.6bNT$16.4bNT$373.5m38.6x44.4x1x
Thu, 07 Oct 2021NT$16.0bNT$16.3bNT$390.9m35.9x41x1x
Sat, 04 Sep 2021NT$21.4bNT$16.3bNT$390.9m46.5x54.8x1.3x
Mon, 02 Aug 2021NT$15.6bNT$16.3bNT$390.9m34.9x39.9x1x
Price to Earnings Ratio

39.9x


Total Market Cap: NT$15.6bTotal Earnings: NT$390.9mTotal Revenue: NT$16.3bTotal Market Cap vs Earnings and Revenue0%0%0%
Taiwanese Drug Retail Industry Price to Earnings3Y Average 43x202220232024
Current Industry PE
  • Investors are optimistic on the Taiwanese Drug Retail industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 50.6x which is higher than its 3-year average PE of 43.0x.
  • The industry is trading close to its 3-year average PS ratio of 1.6x.
Past Earnings Growth
  • The earnings for companies in the Drug Retail industry have grown 31% per year over the last three years.
  • Revenues for these companies have grown 24% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Comparison

How does Taiwanese Drug Retail compare with similar industries?

TW Market-2.30%
Consumer Staples0.28%
Food and Staples Retail0.22%
Drug Retail-0.49%
Food Retail0.39%
Big Box Super Stores0%
Food Distributors-2.40%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
7731 MARX BiotechNT$11.7017.0%
+NT$846.7m		n/an/a
4175 MedFirst Healthcare ServicesNT$75.705.3%
+NT$160.5m		-27.9%PE121.9x
6929 We Can MedicinesNT$67.600.4%
+NT$13.3m		-54.9%PE475.3x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

6469

NT$234.00

Great Tree Pharmacy

7D

-4.3%

1Y

-31.3%

6844

NT$152.50

Norbel Baby

7D

-1.0%

1Y

-26.3%

4175

NT$75.70

MedFirst Healthcare Services

7D

5.3%

1Y

-27.9%

6929

NT$67.60

We Can Medicines

7D

0.4%

1Y

-54.9%

7731

NT$11.70

MARX Biotech

7D

17.0%

1Y

n/a